Lumafield Secures $75 Million in Series C Funding for Advanced X-Ray CT Technology
March 17, 2025 - 11:46
Lumafield, an innovator in industrial X-ray computed tomography (CT) technology, has successfully completed a $75 million Series C funding round. This significant investment underscores the company's pivotal role in the realm of advanced manufacturing, particularly as the United States intensifies its efforts to regain manufacturing leadership.
The funding comes at a crucial time when businesses globally are reassessing their supply chains in light of various strategic challenges. The round was led by IVP and welcomed new investors such as G2 Venture Partners and Wellington Management. Additionally, it saw participation from existing backers including Spark Capital, DCVC, Kleiner Perkins, Lux Capital, and Matter Venture Partners.
With this influx of capital, Lumafield is poised to enhance its technological capabilities and expand its market reach, further solidifying its position in the rapidly evolving manufacturing landscape. The company's innovative solutions are expected to play a key role in shaping the future of manufacturing processes worldwide.
MORE NEWS
June 21, 2026 - 01:52
Mankind must not sacrifice human dignity at the altar of AISome ways of talking about human beings are always out of bounds. Sorting people by economic value into those who merit work and those who should be sidelined is one of them, and any society that...
June 20, 2026 - 18:23
Is Marvell Technology Going to $1 Trillion?Nvidia`s chief executive recently made a bold prediction about Marvell Technology, suggesting the chipmaker could one day join the trillion-dollar club. The comment sparked fresh interest in a...
June 19, 2026 - 18:29
A Tech Twist for Father's Day: New App Brings Old Photos to LifeForget the usual tie or toolbox this Father`s Day. A new mobile application is offering a different kind of gift: the chance to see faded memories with fresh eyes. The app uses simple artificial...
June 19, 2026 - 00:54
FDA panel backs first-of-its-kind flu vaccine using mRNA technologyA new kind of flu vaccine moved a step closer to the U.S. market Thursday. An advisory panel for the Food and Drug Administration voted overwhelmingly in favor of approving the first influenza shot...